E. Ohman J:or Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.7M Buy
564,311
+72,576
+15% +$6.35M 1.2% 14
2026
Q1
$41.9M Buy
491,735
+26,206
+6% +$2.34M 1.11% 17
2025
Q4
$36.8M Sell
465,529
-6,200
-1% -$486K 0.86% 26
2025
Q3
$37.7M Buy
471,729
+32,814
+7% +$2.8M 0.89% 26
2025
Q2
$39.9M Sell
438,915
-23,997
-5% -$2.19M 0.99% 23
2025
Q1
$43.4M Buy
462,912
+76,182
+20% +$6.82M 1.15% 19
2024
Q4
$35.2M Buy
386,730
+354,730
+1,109% +$33.9M 0.82% 31
2024
Q3
$3.32M Buy
32,000
+18,900
+144% +$1.93M 0.08% 107
2024
Q2
$1.27M Hold
13,100
0.03% 222
2024
Q1
$1.18M Sell
13,100
-17,823
-58% -$1.51M 0.03% 227
2023
Q4
$2.46M Sell
30,923
-5,100
-14% -$383K 0.09% 113
2023
Q3
$2.56M Sell
36,023
-505,150
-93% -$37.8M 0.1% 113
2023
Q2
$41.7M Buy
541,173
+76,431
+16% +$5.92M 1.5% 14
2023
Q1
$34.9M Buy
464,742
+95,768
+26% +$7.12M 1.37% 16
2022
Q4
$29.1M Sell
368,974
-56,100
-13% -$4.21M 1.27% 23
2022
Q3
$29.9M Buy
425,074
+43,881
+12% +$3.44M 1.36% 21
2022
Q2
$30.5M Sell
381,193
-76,638
-17% -$5.99M 1.32% 17
2022
Q1
$34.7M Sell
457,831
-54,485
-11% -$4.32M 1.16% 19
2021
Q4
$43.7M Buy
512,316
+54,700
+12% +$4.27M 1.26% 18
2021
Q3
$34.6M Hold
457,616
1.09% 28
2021
Q2
$37.2M Buy
457,616
+26,100
+6% +$2.13M 1.17% 25
2021
Q1
$34M Buy
431,516
+10,300
+2% +$807K 1.23% 23
2020
Q4
$36M Sell
421,216
-6,800
-2% -$562K 1.47% 16
2020
Q3
$33M Sell
428,016
-19,100
-4% -$1.46M 1.63% 15
2020
Q2
$32.8M Buy
447,116
+62,300
+16% +$4.43M 1.88% 14
2020
Q1
$25.5M Sell
384,816
-120,900
-24% -$8.53M 1.87% 16
2019
Q4
$34.8M Buy
505,716
+80,523
+19% +$5.49M 1.93% 12
2019
Q3
$31.3M Sell
425,193
-42,820
-9% -$3.11M 1.97% 12
2019
Q2
$33.5M Buy
468,013
+92,873
+25% +$6.59M 2.2% 13
2019
Q1
$25.7M Buy
375,140
+221
+0.1% +$14.3K 1.73% 16
2018
Q4
$22.3M Buy
374,919
+84,410
+29% +$5.28M 1.62% 16
2018
Q3
$19.4M Buy
290,509
+3,800
+1% +$253K 1.26% 20
2018
Q2
$18.6M Buy
286,709
+40,008
+16% +$2.62M 1.32% 18
2018
Q1
$17.7M Buy
246,701
+221,801
+891% +$16M 1.41% 19
2017
Q4
$1.88M Buy
24,900
+1,900
+8% +$139K 0.15% 98
2017
Q3
$1.68M Buy
23,000
+400
+2% +$28.8K 0.15% 97
2017
Q2
$1.68M Hold
22,600
0.17% 94
2017
Q1
$1.65M Buy
22,600
+1,900
+9% +$133K 0.2% 99
2016
Q4
$1.35M Buy
20,700
+2,200
+12% +$151K 0.19% 100
2016
Q3
$1.37M Buy
18,500
+1,600
+9% +$118K 0.2% 90
2016
Q2
$1.24M Buy
16,900
+2,100
+14% +$150K 0.21% 93
2016
Q1
$1.05M Sell
14,800
-1,800
-11% -$120K 0.19% 99
2015
Q4
$1.11M Buy
16,600
+1,200
+8% +$79.8K 0.19% 97
2015
Q3
$977K Sell
15,400
-2,000
-11% -$131K 0.26% 79
2015
Q2
$1.14M Sell
17,400
-1,500
-8% -$102K 0.27% 80
2015
Q1
$1.31M Hold
18,900
0.3% 73
2014
Q4
$1.32M Sell
18,900
-4,000
-17% -$270K 0.32% 74
2014
Q3
$1.49M Hold
22,900
0.37% 59
2014
Q2
$1.56M Hold
22,900
0.38% 55
2014
Q1
$1.49M Sell
22,900
-1,500
-6% -$94.5K 0.37% 55
2013
Q4
$1.6M Sell
24,400
-600
-2% -$38.4K 0.38% 55
2013
Q3
$1.48M Buy
25,000
+2,100
+9% +$124K 0.38% 57
2013
Q2
$1.31M Buy
+22,900
New +$1.36M 0.36% 52

Other funds holding CL

E. Ohman J:or Asset Management's CL Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Colgate-Palmolive (CL) stake by 15% in Q2 2026, buying an estimated $6.35M and bringing the position to 564,311 shares worth $51.7M. The position accounts for 1.2% of the portfolio, ranked #14.

E. Ohman J:or Asset Management first reported a position in CL in Q2 2013 and has held it in 53 quarters since. 840 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • E. Ohman J:or Asset Management held 564,311 shares of Colgate-Palmolive worth $51.7M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 72,576 Colgate-Palmolive shares in Q2 2026, an estimated $6.35M.
  • Colgate-Palmolive made up 1.2% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #14 holding.
  • E. Ohman J:or Asset Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • 840 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.